http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2284170-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f68b679f44bc15216450ac0a5daa6829
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287235e829eeadb0e006eef83b4d7400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2960cc775c9c531437d3eab6d1bde84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0c258f4261bdc7e27c61f5b28ab4b4
publicationDate 2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2284170-C1
titleOfInvention Method for complex therapy of acquired optic nerve atrophy in children
abstract FIELD: medicine, ophthalmology. n SUBSTANCE: a child should perorally apply hypoxen 1 h before percutaneous electrostimulation at 15 mg/kg body weight, 30 min before electrostimulation a child should be distillated intranasally per 1-2 drops 0.25%-derinate solution into both nasal pathways. Percutaneous electrostimulation should be fulfilled with current power ranged 150-200 mcA, frequency being 30 Hz, not more. Electrode should be initially applied onto nasal, and 30 sec later - onto temporal point of the upper eyelid. One should carry out four series of impacts upon each eye: twice - stimulation of nasal point and twice - of temporal point. Duration of therapy corresponds to 10 d. The innovation increases the degree of reconstructing visual functions due to increased activity of plastic processes. n EFFECT: higher efficiency of complex therapy. n 2 ex, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623870-C1
priorityDate 2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408215224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9811102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1547484

Total number of triples: 30.